{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:08:53Z","timestamp":1772496533370,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/iae.0000000000000093","type":"journal-article","created":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T13:03:54Z","timestamp":1390395834000},"page":"1400-1406","source":"Crossref","is-referenced-by-count":9,"title":["DECREASED MACULAR THICKNESS IN NONPROLIFERATIVE MACULAR TELANGIECTASIA TYPE 2 WITH ORAL CARBONIC ANHYDRASE INHIBITORS"],"prefix":"10.1097","volume":"34","author":[{"given":"John J.","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliott H.","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Folk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinit B.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine N.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Culver","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210130","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(93)31447-8","article-title":"Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study.","volume":"100","author":"Gass","year":"1993","journal-title":"Ophthalmology"},{"key":"R2-17-20210130","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00006982-200509000-00007","article-title":". Long-term juxtafoveal retinal telangiectasia.","volume":"25","author":"Watzke","year":"2005","journal-title":"Retina"},{"key":"R3-17-20210130","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/00006982-199907000-00011","article-title":"Histopathologic study of presumed parafoveal telangiectasis.","volume":"19","author":"Eliassi-Rad","year":"1999","journal-title":"Retina"},{"key":"R4-17-20210130","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.ophtha.2010.04.001","article-title":". Perifoveal muller cell depletion in a case of macular telangiectasia type 2.","volume":"117","author":"Powner","year":"2010","journal-title":"Ophthalmology"},{"key":"R5-17-20210130","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1097\/IAE.0b013e31820d3feb","article-title":". Intravitreal bevacizumab for treatment of proliferative and nonproliferative type 2 idiopathic macular telangiectasia.","volume":"31","author":"Roller","year":"2011","journal-title":"Retina"},{"key":"R6-17-20210130","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00417-007-0567-8","article-title":". Intravitreal bevacizumab (Avastin) for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia.","volume":"245","author":"Mandal","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R7-17-20210130","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00417-009-1117-3","article-title":"Intravitreal ranibizumab as primary treatment for neovascular membrane associated with idiopathic juxtafoveal retinal telangiectasia.","volume":"247","author":"Konstantinidis","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R8-17-20210130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10384-010-0810-4","article-title":"Intravitreal bevacizumab therapy for idiopathic macular telangiectasia.","volume":"54","author":"Matsumoto","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"R9-17-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/IAE.0b013e31818ba9de","article-title":"Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.","volume":"29","author":"Kovach","year":"2009","journal-title":"Retina"},{"key":"R11-17-20210130","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(97)30019-0","article-title":"Grid laser photocoagulation for macular edema in bilateral juxtafoveal telangiectasis.","volume":"104","author":"Park","year":"1997","journal-title":"Ophthalmology"},{"key":"R12-17-20210130","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ajo.2004.06.010","article-title":"Lack of apparent short-term benefit of photodynamic therapy in bilateral, acquired, parafoveal telangiectasis without subretinal neovascularization.","volume":"138","author":"De Lahitte","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R13-17-20210130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/IAE.0b013e31814cf03e","article-title":". Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.","volume":"28","author":"Wu","year":"2008","journal-title":"Retina"},{"key":"R14-17-20210130","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archopht.1988.01060140350030","article-title":"Treatment of chronic macular edema with acetazolamide.","volume":"106","author":"Cox","year":"1988","journal-title":"Arch Ophthalmol"},{"key":"R15-17-20210130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/bjo.2006.107466","article-title":"Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.","volume":"91","author":"Fishman","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R16-17-20210130","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archophthalmol.2010.172","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R17-17-20210130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archophthalmol.2009.398","article-title":"Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.","volume":"128","author":"Genead","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R18-17-20210130","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"R19-17-20210130","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/bmj.314.7098.1874","article-title":"Statistics notes. Units of analysis.","volume":"314","author":"Altman","year":"1997","journal-title":"BMJ"},{"key":"R20-17-20210130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/bjo.82.8.971","article-title":"People and eyes: statistical approaches in ophthalmology.","volume":"82","author":"Murdoch","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"R21-17-20210130","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1167\/iovs.08-2970","article-title":". Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.","volume":"50","author":"Wolf-Schnurrbusch","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-17-20210130","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1167\/iovs.12-10420","article-title":". Reproducibility of diabetic macular edema estimates from SD-OCT is affected by the choice of image analysis algorithm.","volume":"54","author":"Sohn","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-17-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1002143802926","article-title":"The role of carbonic anhydrase inhibitors in the management of macular edema.","volume":"97","author":"Wolfensberger","year":"1999","journal-title":"Doc Ophthalmol"},{"key":"R24-17-20210130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0014-4835(71)90160-6","article-title":"Distribution of carbonic anhydrase in the rabbit eye as demonstrated histochemically.","volume":"12","author":"Bhattacherjee","year":"1971","journal-title":"Exp Eye Res"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000000093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:02:05Z","timestamp":1620954125000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201407000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000000093","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}